Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony stimulating factor administration

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 228-229

  Kawano, C ^a,b   Muroi, K ^a,b   Kuribara, R ^b   Matsumoto, Y ^b   Ohtsuki, T ^b   Hatake, K ^b   Ozawa, K ^a,b  

^a Div Cell Transplant and Transfus   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; METHYLPREDNISOLONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AUTOTRANSPLANTATION; BONE PAIN; CASE REPORT; COLONY FORMING UNIT GM; DYSPNEA; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LETTER; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; WEIGHT GAIN;

EID: 0033965649     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702110     Document Type: Letter

References (10)

1. To LB, Haylock DN, Simmons PL et al. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233-2258.
2. Salazar R, Sola C, Marto P et al. Factors affecting CD34+ cell mobilization with with cyclophosphamide and G-CSF and haematopoietic recovery after high-dose chemotherapy and stem cell support in solid tumour patients. Proc ASCO 1998; 17: 95a.
3. Lee CK, Gingrich, RD, Hohl RJ, Ajram-KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175-182.
4. Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996; 18: 943-947.
5. Rabitsch W, Staudinger T, Brugger SA et al. Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support. Bone Marrow Transplant 1998; 21: 1067-1069.
6. Niitsu N, Iki S, Muroi K et al. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96. Br J Cancer 1997; 76: 1661-1666.
7. Ohsaka A, Kitagawa S, Sakamoto S et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989; 74: 2743-2748.
8. Ericson SG, Zhao Y, Gao H et al. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor. Blood 1998; 91: 2099-2107.
9. Colby C, McAfee SL, Finkelstein, DM et al. Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998; 21: 1005-1010.
10. Kawano Y, Takaue Y, Mimaya J et al. Marginal benefit/ disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT. Blood 1998; 92: 4040-4046.